Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
G-CSF Mobilization in Diabetes
NCT01102699Phase 4Completed
- Sponsor
- Università di Padova
- Start
- Jun 2010
- Primary completion
- Aug 2013
- Modality
- Cytokines & Interferons
- Countries
- 1
01
Overview
Phase 4, open-label trial of filgrastim in diabetes mellitus (DM) (2 arms), sponsored by Università di Padova. Primary endpoint: Circulating Progenitor Cell mobilization at 24 hours. Started Jun 2010; status: completed.
02
Drugs
filgrastim
03
Conditions
diabetes mellitus (DM)
Beyond the preview
Go deeper on NCT01102699.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01102699.